SEC Form 4 · accession 0000899243-19-005281
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joan Mannick
Officer — Chief Medical Officer
Period of report
Feb 27, 2019
Accepted (ET)
Feb 28, 2019 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.53 | Feb 27, 2019 | A | 93,000 | A | — | Feb 26, 2029 | Common Stock | 93,000 | 93,000 | D |
Explanation of responses
- F125% of the shares shall vest on February 27, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.